Inhibition of inflammatory factors by parthenolide in human renal mesangial cells under hyperglycemic condition

African Journal of Biotechnology

Volumn 9, Issue 23, 2010, Pages 3458-3463

  Wang, Wen Juan ^a   Wu, Fang ^b   Qian, Yun ^c   Cheng, Lin Fang ^c   Shao, Xue Ting ^c   Tong, Xiang Min ^c   Li, Hong ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Diabetic nephropathy; Human renal mesangial cells; Inflammatory factors; Parthenolide

Indexed keywords

GLUCOSE; INTERLEUKIN 18; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PARTHENOLIDE; PROSTAGLANDIN E2; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MESANGIUM CELL; PROTEIN EXPRESSION; UPREGULATION;

EID: 80052321719     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Brown Z, Robson RL, Westwick J (1996). Regulation and expression of chemokines: potential role in glomerulonephritis. J. Leukoc. Biol. 59: 75-80.
2. Campbell S, Burkly LC, Gao HX, Berman JW, Su L, Browning B, Zheng T, Schiffer L, Michaelson JS, Putterman C (2006). Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J. Immunol. 176: 1889-1898.
3. Crook M (2004). Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabet. Med. 21: 203-207.
4. DeRubertis FR, Craven PA (1993). Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes. Am. J. Kidney. Dis. 22: 727-735.
5. Dipetrillo K, Coutermarsh B, Gesek FA (2003). Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. Am. J. Physiol. Rena. Physiol. 284: 113-121.
6. Hasegawa G, Nakano K, Sawada M, Uno K, Shibayama Y, Ienaga K, Kondo M (1991). Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney. Int. 40: 1007-1012.
7. Hehner SP, Heinrich M, Bork PM, Vogt M, Ratter F, Lehmann V, Schulze-Osthoff K, Dröge W, Schmitz ML (1998). Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. J. Biol. Chem. 273: 1288-97.
8. Heinrich M, Robles M, West JE, Ortiz de Montellano BR, Rodriguez E (1998). Ethnopharmacology of Mexican asteraceae (Compositae). Annu. Rev. Pharmacol. Toxicol. 38: 539-565.
9. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR (2008). Diabetic nephropathy: mechanisms of renal disease progression. Exp. Biol. Med. (Maywood). 233: 4-11.
10. López-Franco O, Hernández-Vargas P, Ortiz-Muñoz G, Sanjuán G, Suzuki Y, Ortega L, Blanco J, Egido J, Gómez-Guerrero C (2006). Parthenolide modulates the NF-kappaB-mediated inflammatory responses in experimental atherosclerosis. Arterioscler. Thromb. Vascince. Biol. 26: 1864-1870.
11. Mezzano S, Aros C, Droguett A, Burgos ME, Ardiles L, Flores C, Schneider H, Ruiz-Ortega M, Egido J (2004). NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol. Dial. Transplant, 19: 2505-2512.
12. Naito M, Shenoy A, Aoyama I, Koopmeiners JS, Komers R, Schnaper HW, Bomsztyk K (2009). High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin. Am. J. Nephrol. 30: 99-111.
13. Nam NH (2006). Naturally occurring NF-kappaB inhibitors. Mini. Rev. Med. Chem. 6: 945-951.
14. Navarro JF, Mora C (2005). Role of inflammation in diabetic complications. Nephrol. Dial. Transplant. 20: 2601-2604.
15. Pickup JC (2004). Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabet. Care, 27: 813-823.
16. Sánchez-López E, Rodriguez-Vita J, Cartier C, Rupérez M, Esteban V, Carvajal G, Rodrígues-Díez R, Plaza JJ, Egido J, Ruiz-Ortega M (2008). Inhibitory effect of interleukin-1 on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells. Am. J. Physiol. Renal. Physiol. 294: 149-160.
17. Schwarz M, Radeke HH, Resch K, Uciechowski P (1997). Lymphocytederived cytokines induce sequential expression of monocyte- and T cell-specific chemokines in human mesangial cells. Kidney Int. 52: 1521-1531.
18. Shui HA, Ka SM, Wu WM, Lin YF, Hou YC, Su LC, Chen A (2007). LPSevoked IL-18 expression in mesangial cells plays a role in accelerating lupus nephritis. Rheumatol. (Oxford). 46: 1277-1284.
19. Teramoto K, Negoro N, Kitamoto K, Iwai T, Iwao H, Okamura M, Miura K (2008). Microarray analysis of glomerular gene expression in murine lupus nephritis. J. Pharmacol. Sci. 106: 56-67.
20. Viberti G C, Benigni A, Bognetti E, Remuzzi G, Wiseman M J (1989). Glomerular hyperfiltration and urinary prostaglandins in type 1 diabetes mellitus. Diabet. Med. 6: 219-223.
21. Wang JJ, Zhang SX, Mott R, Chen Y, Knapp RR, Cao W, Ma JX (2008). Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 294: 1166-1173.
22. Wu F, Yao H, Bader A, Dong F, Zhu F, Wu N, Wang B, Li H, Brockmeyer NH, Altmeyer P (2007). Decorin gene transfer inhibited the expression of TGF1 and ECM in rat mesangial cells. Eur. J. Med. Res. 12: 360-368.
23. Yao H, Tang X, Shao X, Feng L, Wu N, Yao K (2007). Parthenolide protects human lens epithelial cells from oxidative stress-induced apoptosis via inhibition of activation of caspase-3 and caspase-9. Cell. Res. 17: 565-571.
24. Yu Z, Zhang W, Kone BC (2002). Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kB. Biochemistry, J. 367: 97-105.